Drug · DIN 02237517 · Veterinary
PROGRAM 40
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 31, 2025; first marketed May 5, 1998.
- Drug Identification Number (DIN)
- 02237517
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Suspension
- Route
- Subcutaneous
- Class
- Veterinary
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LUFENURON | 40 MG | 0.4 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 21, 2021: NOC 25704Supplement to a New Drug Submission (SNDS) · Labelling update
- April 20, 2020: NOC 23484Supplement to a New Drug Submission (SNDS) · Manufacturing change
- June 18, 2018: NOC 20994Supplement to a New Drug Submission (SNDS) · Alternate manufacturing site
- December 23, 2015: NOC 17610New Drug Submission (NDS) · Merger - buyout
- February 15, 2007: NOC 8600Supplement to a New Drug Submission (SNDS) · Change in manufacturing site
- March 4, 1998: NOC 6891New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “program”. A notice may cover another product or only some lots: read it to see what it covers.
- ISTODAX (romidepsin) – Restricted Access ProgramMarch 20, 2023 · Drugs · New safety information - Product withdrawal